ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

NAS Honors David Kessler; Satcher Seeks Obesity Plan.

January 12, 2001

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

NIH Consensus Conference Agenda, Registration Online.

September 1, 2000

Clinical Trials Approved By NCI CTEP Last Month

January 28, 2011